Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Events

    Evaluation of Corporate Compliance Programs

    5th Annual Advanced Anti-Bribery Boot Camp

    August 24, 2017

    People

    James G. Munisteri

    Houston 713.276.5752

    Related Insights

    View All Posts
    July 22, 2025 Health Care Law Today

    GLP-1 Receptor Agonists: Clinical Trial Considerations

    The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
    July 21, 2025 Energy Current

    DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now

    Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
    July 21, 2025 Labor & Employment Law Perspectives

    Considering a Reduction in Force? Some Preliminary Considerations

    Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…